Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.69 - $1.21 $19,721 - $34,584
-28,582 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.02 - $3.8 $2,052 - $7,645
-2,012 Reduced 6.58%
28,582 $34,000
Q4 2021

Feb 11, 2022

SELL
$3.26 - $4.66 $2,982 - $4,263
-915 Reduced 2.9%
30,594 $100,000
Q3 2021

Nov 12, 2021

SELL
$4.08 - $5.66 $3,055 - $4,239
-749 Reduced 2.32%
31,509 $141,000
Q2 2021

Aug 13, 2021

BUY
$5.01 - $7.48 $23,827 - $35,574
4,756 Added 17.29%
32,258 $176,000
Q1 2021

May 07, 2021

BUY
$7.19 - $14.95 $24,223 - $50,366
3,369 Added 13.96%
27,502 $206,000
Q4 2020

Feb 12, 2021

SELL
$6.66 - $14.66 $4,608 - $10,144
-692 Reduced 2.79%
24,133 $262,000
Q3 2020

Nov 04, 2020

SELL
$8.69 - $14.47 $4,909 - $8,175
-565 Reduced 2.23%
24,825 $220,000
Q2 2020

Aug 12, 2020

BUY
$5.21 - $11.03 $25,409 - $53,793
4,877 Added 23.78%
25,390 $271,000
Q1 2020

May 04, 2020

SELL
$4.46 - $9.2 $5,289 - $10,911
-1,186 Reduced 5.47%
20,513 $122,000
Q4 2019

Feb 05, 2020

SELL
$4.52 - $10.1 $827 - $1,848
-183 Reduced 0.84%
21,699 $150,000
Q3 2019

Nov 08, 2019

SELL
$7.14 - $11.65 $1,085 - $1,770
-152 Reduced 0.69%
21,882 $227,000
Q2 2019

Aug 13, 2019

BUY
$5.5 - $9.75 $32,461 - $57,544
5,902 Added 36.59%
22,034 $204,000
Q1 2019

May 06, 2019

SELL
$5.51 - $9.59 $2,881 - $5,015
-523 Reduced 3.14%
16,132 $147,000
Q4 2018

Feb 13, 2019

SELL
$5.55 - $11.34 $710 - $1,451
-128 Reduced 0.76%
16,655 $93,000
Q3 2018

Nov 09, 2018

BUY
$9.74 - $12.92 $8,084 - $10,723
830 Added 5.2%
16,783 $200,000
Q2 2018

Aug 08, 2018

BUY
$10.16 - $13.65 $61,671 - $82,855
6,070 Added 61.42%
15,953 $163,000
Q1 2018

May 07, 2018

BUY
$9.47 - $12.98 $13,797 - $18,911
1,457 Added 17.29%
9,883 $128,000
Q4 2017

Feb 09, 2018

BUY
$8.45 - $17.48 $329 - $681
39 Added 0.47%
8,426 $82,000
Q3 2017

Nov 09, 2017

BUY
$13.52 - $23.75 $113,392 - $199,191
8,387
8,387 $123,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $40.5M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.